Arista Wealth Management LLC Purchases New Position in Healthpeak Properties, Inc. $DOC

Key Points

• Arista Wealth Management LLC acquired a new stake in Healthpeak Properties, purchasing 16,391 shares valued at approximately $287,000 in the second quarter.
• Healthpeak Properties' recent quarterly earnings showed an EPS of $0.46, meeting analyst expectations, while revenue decreased by 0.2% year-over-year to $694.35 million.
• The firm announced a monthly dividend of $0.1017 per share with a dividend yield of 6.6%, although it has a high dividend payout ratio of 508.33%.

Arista Wealth Management LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 16,391 shares of the real estate investment trust's stock, valued at approximately $287,000.

Other large investors have also recently modified their holdings of the company. Brooklyn Investment Group boosted its holdings in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 873 shares during the period. TCTC Holdings LLC boosted its holdings in shares of Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the period. S.A. Mason LLC boosted its holdings in shares of Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares during the period. Dagco Inc. purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $30,000. Finally, GKV Capital Management Co. Inc. purchased a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $36,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

Shares of DOC opened at $18.55 on Friday. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $23.26. The stock has a fifty day moving average price of $18.16 and a 200-day moving average price of $17.91. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market cap of $12.89 billion, a PE ratio of 77.27, a P/E/G ratio of 3.15 and a beta of 1.09.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same quarter in the prior year, the business posted $0.45 EPS. The business's revenue for the quarter was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.6%. The ex-dividend date is Friday, December 19th. Healthpeak Properties's dividend payout ratio is currently 508.33%.

Insider Activity at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 1,490 shares of the business's stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average cost of $16.83 per share, with a total value of $25,076.70. Following the transaction, the chief executive officer directly owned 211,906 shares in the company, valued at approximately $3,566,377.98. The trade was a 0.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last ninety days, insiders acquired 8,783 shares of company stock worth $150,129. Corporate insiders own 0.23% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their target price for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Cantor Fitzgerald assumed coverage on Healthpeak Properties in a report on Wednesday, October 1st. They set a "neutral" rating and a $20.00 target price for the company. Wells Fargo & Company lowered their target price on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a report on Wednesday, August 27th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Finally, Raymond James Financial upgraded Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 target price for the company in a report on Monday, September 15th. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties currently has an average rating of "Moderate Buy" and an average target price of $21.33.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.